AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer.

AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer. Clin Cancer Res. 2020 08 15; 26(16):4349-4359.

View in: PubMed

subject areas

Animals
Cell Line, Tumor
Cetuximab
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Genes, abl
Head and Neck Neoplasms
Humans
Mice
Neoplasm Recurrence, Local
Proteomics
Proto-Oncogene Proteins
Radiation Tolerance
Receptor Protein-Tyrosine Kinases
Signal Transduction
Tyrosine
Xenograft Model Antitumor Assays

authors with profiles

Ravi Salgia